 |
|
Research to provide information of long-term effects of childhood cancer treatment to parents
February 05, 2009How and when parents need to obtain information about delayed effects associated with childhood cancer treatment
PROVIDENCE, RI - Researchers from the neuropsychology department and pediatric hematology/oncology department at Rhode Island Hospital and its Hasbro Children's Hospital have published the results of their findings on parents' needs for information about the neurocognitive late effects (NCLE) of treatment for childhood cancer. The findings indicate that although parents report feeling knowledgeable about NCLE, they continue to need further information. The study was first published online for the journal Pediatric Blood & Cancer, and appears in the Feb. 2009 print edition.
The incidence of pediatric cancer has increased, however, the mortality rates of childhood cancer have decreased, resulting in more survivors. Along with that improvement comes what is known as "late effects" associated with the treatment children with cancer receive. These effects are often chronic problems, such as memory and concentration problems or difficulty in learning, problem solving, or processing and organizing information that can develop two or more years after treatment is completed. Fifty to 60 percent of all childhood cancer survivors are at risk for NCLE. In particular, children with central nervous system tumors and leukemia have an increased risk.
Previous research in this area has primarily focused on information needs related to diagnosis, treatment and prognosis. This study, however, extended those findings to examine the parents' needs for information specifically about NCLE. The researchers surveyed a total of 90 parents whose children were undergoing or completed cancer treatment with a series of questionnaires to determine their perceived knowledge of NCLE and the need for further information. The study also took into account the parents' coping style, perceived risk for NCLE, stress, and information related to each child's diagnosis and treatment.
The study's overall goal was to first determine what preferences the parents had for obtaining information on NCLE and what causes parents to want more or less information.
Lead author Christine Trask, PhD, ABPP, of the neuropsychology program at Rhode Island Hospital says, "This study showed us that parents had a moderately positive satisfaction level with regard to the information they received about NCLE, but it is also clear that there is a strong desire across all groups to know more." Trask also notes, "One particularly interesting finding is that parents had significant variability about when they wanted to receive information about NCLE. Parents who reported higher levels of emotional distress, lower levels of education, or who had a child with leukemia reported wanting to receive more information on NCLE as early as possible."
The researchers note that as mortality from childhood cancer decreases and survival increases, oncologists are now faced with a struggle of how and when to present information on NCLE to parents. The time of diagnosis is often a time of high levels of stress and emotional distress for parents, and this may present some difficulties in their processing of information. Oncologists, therefore, must make a determination about when to present the information on the potential risks of NCLE to these parents.
Trask reports, "The findings from this study suggest that parents continue to have high needs for information about NCLE both during and after treatment. As a result, we recommend that health care professionals monitor parents' understanding and needs for information, even after completion of treatment when visits become less frequent."
The study also suggests that there is an association between parental distress and the timing of information. Trask comments, "If early provision of information helps prevent parental distress, this would provide a rationale for more thorough discussion of NCLE at the time of diagnosis."
One of the more surprising outcomes of the study was the lack of association between measures of parental coping and informational needs when compared to research in adult patients. Measures of tolerance of uncertainty and coping styles were not predictive of parents' informational needs. Trask says, "One hypothesis might be that there is a different response when caring for and making decisions for your child than when making health-care decisions for yourself."
Lifespan
Previous research in this area has primarily focused on information needs related to diagnosis, treatment and prognosis. This study, however, extended those findings to examine the parents' needs for information specifically about NCLE. The researchers surveyed a total of 90 parents whose children were undergoing or completed cancer treatment with a series of questionnaires to determine their perceived knowledge of NCLE and the need for further information. The study also took into account the parents' coping style, perceived risk for NCLE, stress, and information related to each child's diagnosis and treatment.
The study's overall goal was to first determine what preferences the parents had for obtaining information on NCLE and what causes parents to want more or less information.
Lead author Christine Trask, PhD, ABPP, of the neuropsychology program at Rhode Island Hospital says, "This study showed us that parents had a moderately positive satisfaction level with regard to the information they received about NCLE, but it is also clear that there is a strong desire across all groups to know more." Trask also notes, "One particularly interesting finding is that parents had significant variability about when they wanted to receive information about NCLE. Parents who reported higher levels of emotional distress, lower levels of education, or who had a child with leukemia reported wanting to receive more information on NCLE as early as possible."
The researchers note that as mortality from childhood cancer decreases and survival increases, oncologists are now faced with a struggle of how and when to present information on NCLE to parents. The time of diagnosis is often a time of high levels of stress and emotional distress for parents, and this may present some difficulties in their processing of information. Oncologists, therefore, must make a determination about when to present the information on the potential risks of NCLE to these parents.
Trask reports, "The findings from this study suggest that parents continue to have high needs for information about NCLE both during and after treatment. As a result, we recommend that health care professionals monitor parents' understanding and needs for information, even after completion of treatment when visits become less frequent."
The study also suggests that there is an association between parental distress and the timing of information. Trask comments, "If early provision of information helps prevent parental distress, this would provide a rationale for more thorough discussion of NCLE at the time of diagnosis."
One of the more surprising outcomes of the study was the lack of association between measures of parental coping and informational needs when compared to research in adult patients. Measures of tolerance of uncertainty and coping styles were not predictive of parents' informational needs. Trask says, "One hypothesis might be that there is a different response when caring for and making decisions for your child than when making health-care decisions for yourself."
Lifespan
Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia
Scientists at St. Jude Children's Research Hospital have identified inherited variations in two genes that account for 37 percent of childhood acute lymphoblastic leukemia (ALL), including a gene that may help predict drug response.
Sperm banking before treatment preserves fertility in young male cancer patients
A recent study at Hamilton Health Sciences proves that sperm freezing and banking is an effective way to preserve fertility in adolescents and young adult (AYA) males with cancer.
Teenage Cancer Trust demands government action to aid young cancer patients
Survival rates suffer as teens and young adults' needs are ignored says charity London, UK: Teenagers and young adults have been neglected, ignored and 'defined out of existence' by the government and the NHS, the head of a UK cancer charity said today (1 March). They suffer from late diagnosis, they are denied the chance to take part in clinical trials and they get shuttled between the vastly different specialities of child and adult oncology. Improvements in survival now lag behind those of children and older adults and young people face the ordeal of a life-threatening disease with little support or acknowledgement that they have any special needs. Mrs Myrna Whiteson, chairman of Teenage
More Childhood Cancer Treatment Current Events and Childhood Cancer Treatment News Articles
 |
Endocrinopathy After Childhood Cancer Treatment (Endocrine Development) by W. H. B. Wallace (Editor), C. J. H. Kelnar (Editor) |
 |
2009 Conquering Cancer - The Empowered Patient's Complete Reference to Childhood Cancer - Diagnosis, Treatment Options, Prognosis (Two CD-ROM Set) by PM Medical Health News (Author) This up-to-date and comprehensive set of two CD-ROM discs provides a superb collection of official Federal government documents on childhood cancer: signs and symptoms, diagnosis, lab tests, treatment and management options, and ongoing clinical research. Every aspect of the disease is thoroughly covered. Tumors covered include: Brain Tumor (Brain Stem Glioma, Cerebellar Astrocytoma, Cerebral Astrocytoma, Ependymoma, Medulloblastoma, Supratentorial Primitive Neuroectodermal and Pineal Tumors, Visual Pathway and Hypothalamic Glioma, Other Brain Tumors); Ewing's Sarcoma Family of Tumors; Germ Cell Tumor, Extracranial Hodgkin's Disease; Leukemia; Leukemia, Acute Lymphoblastic; Leukemia, Acute Myeloid; Liver Cancer; Neuroblastoma; Non-Hodgkin's Lymphoma; Osteosarcoma/Malignant Fibrous... |
 |
Childhood Cancer Survivors: A Practical Guide to Your Future (Childhood Cancer Guides) by Nancy Keene (Author), Wendy Hobbie (Author), Kathy Ruccione (Author) More than 270,000 children, teens, and adults in the Untied States are survivors of childhood cancer. The surgery, radiation, chemotherapy, and stem cell transplants used to cure children can affect growing bodies and developing minds. If survivors know of these potential problems, they can take steps to identify, cope with, or treat them early if they do develop. The second edition of "Childhood Cancer Survivors" charts the territory for survivors by providing state-of-the-art information about: Medical late effects from treatment Emotional aspects of surviving cancer Schedules for follow-up care Challenges in the heathcare system Lifestyle choices to maximize health Discrimination in employment of insurance Authors Keene, Hobbie, and Ruccione are experts in the field of childhood... |
|
Childhood Cancer: A Parent's Guide to Solid Tumor Cancers [With Cancer Survivor's Treatment Record] [CHILDHOOD CANCER 2/E] by Honna(Author) ; Keene, Nancy(Joint Author) Janes-Hodder (Author) | |
 |
Cardiac Toxicity After Treatment for Childhood Cancer by Daniel M. Green (Author), J. Timothy, M.D. Bricker (Author), Daniel M. Green (Editor), J. Timothy, M.D. Bricker (Editor), Giulio J. D'Angio (Editor) Texas Children's Hospital, Houston, Texas. Papers presented at the Second International Conference on the Long-Term Complications of Treatment of Children and Adolescents with Cancer, June 12-14, 1992, Buffalo, New York. 32 U.S. contributors. |
|
Late Effects of Treatment for Childhood Cancer (Current Clinical Oncology) by Daniel M. Green (Author), Giulio J. D'Angio (Editor) Discussing the long-term medical, developmental and psychological effects, this book covers the different forms of treatment for the various cancers that occur in childhood and adolescence. Presenting a broad range of detailed papers, the text deals with the most common types of paediatric cancer and considers major treatment modalities such as chemotherapy, radiation therapy and surgery. | |
 |
Childhood Cancer: A Parent's Guide to Solid Tumor Cancers, 2nd Edition by Honna Janes-Hodder (Author), Nancy Keene (Author) This second edition of the most complete parent guide available, features detailed and precise medical information about solid tumor childhood cancers, including neuroblastoma, Wilms tumor, liver tumors, soft tissue sarcomas, and bone sarcomas. In addition, it offers day-to-day practical advice on how to cope with procedures, hospitalization, family and friends, school, social and financial issues, communication, feelings, and, if therapy is not successful, the difficult issues of death and bereavement. Woven among the medical details and the practical advice are the voices of parents and children who have lived with cancer and its treatments. Parents who read this book will encounter medical facts simply explained, advice to ease their daily lives, and tools to be strong advocates for... |
|
Childhood Leukemia, 3rd Edition [With Cancer Survivor's Treatment Record] [CHILDHOOD LEUKEMIA 3RD /E 3/E] [Paperback] by Nancy(Author) Keene (Author) | |
|
Childhood Brain & Spinal Cord Tumors: A Guide for Families, Friends & Caregivers [With Cancer Survivor's Treatment Record Booklet] [CHILDHOOD BRAIN & SPINAL CORD] by Tania(Author) ; Cullen, Patsy McGuire(Joint Author); Sansalone, Maria(Joint Author) Shiminski-Maher (Author) | |
 |
Childhood Cancer: Information for the Patient and Family by Ronald D. Barr (Author) This vital resource provides an up-to-date and informative account of childhood cancer. The purpose of this book is to provide a source of information and guidance for children with cancer and for their families. It is intended to help them understand their new experiences and so reduce the fear that accompanies uncertainty. The material is meant to complement and not substitute the essential continuing dialogue between families and members of the health care team. |
| © 2009 BrightSurf.com |